Insights

Strategic funding Ictero Medical has secured a $6M Series A in 2022 led by MedTex Ventures and S3 Ventures with strategic investor participation, indicating investor confidence and potential for follow-on rounds and partner leverage for early adopters.

Clinical focus The company is developing a minimally-invasive cryoablation system to treat gallstone disease, targeting high-risk patients, which presents a clear clinical need and a potential trigger for collaboration with hospitals and GI centers.

Growth potential Despite a small team (2-10 employees) and early-stage revenue, the backing by notable venture funds and strategic investors, plus collaborations with Texas Medical Center, suggests readiness for accelerated development and pilot programs with large health systems.

Strategic partnerships Previous engagement with Texas Medical Center and public coverage of investor-backed financing imply opportunities to pursue academic partnerships, clinical trials, and joint development with leading medical institutions.

Market entry path As a niche medical device startup with a novel cryoablation approach, Ictero Medical may seek early adopters among high-risk gallstone patients; sales outreach can target GI/hepato-biliary surgeons, interventional radiologists, and hospital procurement at academic centers and early-adopter hospitals.

Ictero Medical Tech Stack

Ictero Medical uses 8 technology products and services including cdnjs, MySQL, oEmbed, and more. Explore Ictero Medical's tech stack below.

  • cdnjs
    Content Delivery Network
  • MySQL
    Database
  • oEmbed
    Dev Tools
  • Google Fonts API
    Font Scripts
  • Google Search Console
    Web Analytics
  • GoDaddy
    Web Hosting
  • Contact Form 7
    Web Platform Extensions
  • Nginx
    Web Servers

Media & News

Ictero Medical's Email Address Formats

Ictero Medical uses at least 1 format(s):
Ictero Medical Email FormatsExamplePercentage
First.Last@icteromedical.comJohn.Doe@icteromedical.com
100%

Frequently Asked Questions

What is Ictero Medical's official website and social media links?

Minus sign iconPlus sign icon
Ictero Medical's official website is icteromedical.com and has social profiles on LinkedInCrunchbase.

How much revenue does Ictero Medical generate?

Minus sign iconPlus sign icon
As of July 2026, Ictero Medical's annual revenue is estimated to be <$1M.

What is Ictero Medical's NAICS code?

Minus sign iconPlus sign icon
Ictero Medical's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Ictero Medical have currently?

Minus sign iconPlus sign icon
As of July 2026, Ictero Medical has approximately 3 employees across 1 continents, including North America. Key team members include Board Observer: J. S.. Explore Ictero Medical's employee directory with LeadIQ.

What industry does Ictero Medical belong to?

Minus sign iconPlus sign icon
Ictero Medical operates in the Medical Equipment Manufacturing industry.

What technology does Ictero Medical use?

Minus sign iconPlus sign icon
Ictero Medical's tech stack includes cdnjsMySQLoEmbedGoogle Fonts APIGoogle Search ConsoleGoDaddyContact Form 7Nginx.

What is Ictero Medical's email format?

Minus sign iconPlus sign icon
Ictero Medical's email format typically follows the pattern of First.Last@icteromedical.com. Find more Ictero Medical email formats with LeadIQ.

How much funding has Ictero Medical raised to date?

Minus sign iconPlus sign icon
As of July 2026, Ictero Medical has raised $15M in funding. The last funding round occurred on Apr 29, 2022 for $2.5M.

When was Ictero Medical founded?

Minus sign iconPlus sign icon
Ictero Medical was founded in 2018.
Ictero Medical logo

Ictero Medical

Medical Equipment ManufacturingTexas, United States2-10 Employees

Ictero Medical is a medical equipment company based in Houston, Texas, developing a minimally invasive cryoablation system intended to treat gallstone disease in high-risk patients. The firm's work focuses on providing a catheter-based approach aimed at reducing procedural risk and enabling treatment for individuals who may not tolerate more invasive options. Positioned within the medical device sector, Ictero Medical emphasizes devices designed to address gallbladder disease and related conditions, seeking to expand options for a patient population with limited alternatives. The company operates on a small team and has engaged with industry partners and medical centers to advance its technology, with recent activity indicating progress in bringing its minimally invasive solution closer to clinical use. } }\n} } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } }

Section iconCompany Overview

NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2018
Employees
2-10

Section iconFunding & Financials

  • $15M

    Ictero Medical has raised a total of $15M of funding over 8 rounds. Their latest funding round was raised on Apr 29, 2022 in the amount of $2.5Mas a series_a.

  • <$1M

    Ictero Medical's revenue is estimated to be in the range of <$1M

Section iconFunding & Financials

  • $15M

    Ictero Medical has raised a total of $15M of funding over 8 rounds. Their latest funding round was raised on Apr 29, 2022 in the amount of $2.5Mas a series_a.

  • <$1M

    Ictero Medical's revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.